U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Description

Forigerimod (also known as IPP-201101) a phosphopeptide is being investigated for the treatment of Lupus Erythematosus, Systemic. This drug is completed phase III clinical trials and is ready for licensing.

Approval Year

Unknown
149124
PubMed

PubMed

TitleDatePubMed
A general preparation of protected phosphoamino acids.
2012-03-02

Sample Use Guides

In Vivo Use Guide
200 mcg of IPP-201101 (FORIGERIMOD) will be administered subcutaneously every 4 weeks for 24 weeks.
Route of Administration: Other
Name Type Language
IPP-201101
Preferred Name English
FORIGERIMOD
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
forigerimod [INN]
Common Name English
RIGERIMOD
Common Name English
L-TYROSINE, L-ARGINYL-L-ISOLEUCYL-L-HISTIDYL-L-METHIONYL-L-VALYL-L-TYROSYL-L-SERYL-L-LYSYL-L-ARGINYL-O-PHOSPHONO-L-SERYLGLYCYL-L-LYSYL-L-PROLYL-L-ARGINYLGLYCYL-L-TYROSYL-L-ALANYL-L-PHENYLALANYL-L-ISOLEUCYL-L-.ALPHA.-GLUTAMYL-
Common Name English
FORIGERIMOD [USAN]
Common Name English
Forigerimod [WHO-DD]
Common Name English
IPP201101
Code English
Code System Code Type Description
FDA UNII
1JRB6UKG4Q
Created by admin on Mon Mar 31 21:19:52 GMT 2025 , Edited by admin on Mon Mar 31 21:19:52 GMT 2025
PRIMARY
ChEMBL
CHEMBL2103866
Created by admin on Mon Mar 31 21:19:52 GMT 2025 , Edited by admin on Mon Mar 31 21:19:52 GMT 2025
PRIMARY
USAN
XX-41
Created by admin on Mon Mar 31 21:19:52 GMT 2025 , Edited by admin on Mon Mar 31 21:19:52 GMT 2025
PRIMARY
INN
9405
Created by admin on Mon Mar 31 21:19:52 GMT 2025 , Edited by admin on Mon Mar 31 21:19:52 GMT 2025
PRIMARY
NCI_THESAURUS
C166505
Created by admin on Mon Mar 31 21:19:52 GMT 2025 , Edited by admin on Mon Mar 31 21:19:52 GMT 2025
PRIMARY
CAS
497156-60-2
Created by admin on Mon Mar 31 21:19:52 GMT 2025 , Edited by admin on Mon Mar 31 21:19:52 GMT 2025
PRIMARY
SMS_ID
100000175203
Created by admin on Mon Mar 31 21:19:52 GMT 2025 , Edited by admin on Mon Mar 31 21:19:52 GMT 2025
PRIMARY
DRUG BANK
DB12490
Created by admin on Mon Mar 31 21:19:52 GMT 2025 , Edited by admin on Mon Mar 31 21:19:52 GMT 2025
PRIMARY
ACTIVE MOIETY
FORIGERIMOD
SALT/SOLVATE (PARENT)
FORIGERIMOD ACETATE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966